Literature DB >> 27239120

Longitudinal molecular characterization of endoscopic specimens from colorectal lesions.

Petra Minarikova1, Lucie Benesova1, Tereza Halkova1, Barbora Belsanova1, Stepan Suchanek1, Jiri Cyrany1, Inna Tuckova1, Jan Bures1, Miroslav Zavoral1, Marek Minarik1.   

Abstract

AIM: To compare molecular profiles of proximal colon, distal colon and rectum in large adenomas, early and late carcinomas. To assess feasibility of testing directed at molecular markers from this study in routine clinical practice.
METHODS: A prospective 3-year study has resulted in the acquisition of samples from 159 large adenomas and 138 carcinomas along with associated clinical parameters including localization, grade and histological type for adenomas and localization and stage for carcinomas. A complex molecular phenotyping has been performed using multiplex ligation-dependent probe amplification technique for the evaluation of CpG-island methylator phenotype (CIMP), PCR fragment analysis for detection of microsatellite instability and denaturing capillary electrophoresis for sensitive detection of somatic mutations in KRAS, BRAF, TP53 and APC genes.
RESULTS: Molecular types according to previously introduced Jass classification have been evaluated for large adenomas and early and late carcinomas. An increase in CIMP+ type, eventually accompanied with KRAS mutations, was notable between large adenomas and early carcinomas. As expected, the longitudinal observations revealed a correlation of the CIMP+/BRAF+ type with proximal location.
CONCLUSION: Prospective molecular classification of tissue specimens is feasible in routine endoscopy practice. Increased frequency of some molecular types corresponds to the developmental stages of colorectal tumors. As expected, a clear distinction is notable for tumors located in proximal colon supposedly arising from the serrated (methylation) pathway.

Entities:  

Keywords:  BRAF; Colorectal cancer; CpG-island methylator phenotype; DNA; Microsatellite instability

Mesh:

Substances:

Year:  2016        PMID: 27239120      PMCID: PMC4873886          DOI: 10.3748/wjg.v22.i20.4936

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  51 in total

1.  KRAS mutations: an old oncogene becomes a new predictive biomarker.

Authors:  Gregory J Riely; Marc Ladanyi
Journal:  J Mol Diagn       Date:  2008-10-02       Impact factor: 5.568

Review 2.  The chromosomal instability pathway in colon cancer.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

3.  Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles.

Authors:  P Minoo; I Zlobec; M Peterson; L Terracciano; A Lugli
Journal:  Int J Oncol       Date:  2010-09       Impact factor: 5.650

4.  BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.

Authors:  Shi Yang; Francis A Farraye; Charline Mack; Oksana Posnik; Michael J O'Brien
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

5.  CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.

Authors:  Yu-Wei Cheng; Hanna Pincas; Manny D Bacolod; Gunter Schemmann; Sarah F Giardina; Jianmin Huang; Sandra Barral; Kamran Idrees; Sajid A Khan; Zhaoshi Zeng; Shoshana Rosenberg; Daniel A Notterman; Jurg Ott; Philip Paty; Francis Barany
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

6.  Genomic instability occurs in colorectal carcinomas but not in adenomas.

Authors:  J Young; B Leggett; C Gustafson; M Ward; J Searle; L Thomas; R Buttenshaw; G Chenevix-Trench
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

7.  Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.

Authors:  Oana C Rafael; Mohamed Aziz; Harry Raftopoulos; Oana E Vele; Weisheng Xu; Chiara Sugrue
Journal:  Cancer Cytopathol       Date:  2014-04-10       Impact factor: 5.284

Review 8.  Are there two sides to colorectal cancer?

Authors:  Barry Iacopetta
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

9.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors:  Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 16.971

10.  Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

Authors:  Paul Lochhead; Aya Kuchiba; Yu Imamura; Xiaoyun Liao; Mai Yamauchi; Reiko Nishihara; Zhi Rong Qian; Teppei Morikawa; Jeanne Shen; Jeffrey A Meyerhardt; Charles S Fuchs; Shuji Ogino
Journal:  J Natl Cancer Inst       Date:  2013-07-22       Impact factor: 13.506

View more
  4 in total

1.  Detection and Quantification of ctDNA for Longitudinal Monitoring of Treatment in Non-Small Cell Lung Cancer Patients Using a Universal Mutant Detection Assay by Denaturing Capillary Electrophoresis.

Authors:  Lucie Benesova; Renata Ptackova; Tereza Halkova; Anastasiya Semyakina; Martin Svaton; Ondrej Fiala; Milos Pesek; Marek Minarik
Journal:  Pathol Oncol Res       Date:  2022-06-28       Impact factor: 2.874

2.  Somatic Mutations in Exon 7 of the TP53 Gene in Index Colorectal Lesions Are Associated with the Early Occurrence of Metachronous Adenoma.

Authors:  Tereza Hálková; Renata Ptáčková; Anastasiya Semyakina; Štěpán Suchánek; Eva Traboulsi; Ondřej Ngo; Kateřina Hejcmanová; Ondřej Májek; Jan Bureš; Miroslav Zavoral; Marek Minárik; Lucie Benešová
Journal:  Cancers (Basel)       Date:  2022-06-07       Impact factor: 6.575

3.  Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Shailesh M Advani; Pragati Advani; Stacia M DeSantis; Derek Brown; Helena M VonVille; Michael Lam; Jonathan M Loree; Amir Mehrvarz Sarshekeh; Jan Bressler; David S Lopez; Carrie R Daniel; Michael D Swartz; Scott Kopetz
Journal:  Transl Oncol       Date:  2018-07-30       Impact factor: 4.243

4.  Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.

Authors:  Shailesh Mahesh Advani; Pragati Shailesh Advani; Derek W Brown; Stacia M DeSantis; Krittiya Korphaisarn; Helena M VonVille; Jan Bressler; David S Lopez; Jennifer S Davis; Carrie R Daniel; Amir Mehrvarz Sarshekeh; Dejana Braithwaite; Michael D Swartz; Scott Kopetz
Journal:  BMC Cancer       Date:  2019-10-17       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.